Next, we extended our analysis to a subset of patients with ongoing PCC symptoms for which levels of IL-5, IL-9, L-17F, IL-18, IL-22, IL-23, IL-33, CCL2/MCP-1, soluble CD206 (MMR), and soluble CD163 were available. This evidence concerns the gene IL9 and adrenal gland pheochromocytoma.